Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D John Betteridge

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Atherosclerosis. Supplements|November 14, 2002
Plant sterols...from research to practiceD John Betteridge
Fundamental & Clinical Pharmacology|September 12, 2009
CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazoneD John Betteridge
Current Opinion in Lipidology|October 30, 2008
Lipid lowering in diabetes mellitusD John Betteridge
Nature Reviews. Cardiology|March 16, 2011
Lipid control in patients with diabetes mellitusD John Betteridge
Diabetes Research and Clinical Practice|May 12, 2005
Long-term risk reduction: who needs treatment?D John Betteridge
Nature Reviews. Endocrinology|January 9, 2013
Cardiovascular endocrinology in 2012: PCSK9-an exciting target for reducing LDL-cholesterol levelsD John Betteridge
Diabetes, Obesity & Metabolism|August 19, 2007
Effects of pioglitazone on lipid and lipoprotein metabolismD John Betteridge
Current Atherosclerosis Reports|May 1, 2019
Diabetogenic Action of Statins: MechanismsRafael Carmena, D John Betteridge
Diabetes Research and Clinical Practice|July 26, 2003
CHD and diabetes--target dyslipidaemia, reduce the riskD John Betteridge, Jaakko Tuomilehto
Seminars in Vascular Medicine|April 30, 2005
Statins and diabetesRafael Carmena, D John Betteridge
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Atherosclerosis. Supplements|November 14, 2002
Plant sterols...from research to practiceD John Betteridge
Fundamental & Clinical Pharmacology|September 12, 2009
CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazoneD John Betteridge
Current Opinion in Lipidology|October 30, 2008
Lipid lowering in diabetes mellitusD John Betteridge
Nature Reviews. Cardiology|March 16, 2011
Lipid control in patients with diabetes mellitusD John Betteridge
Diabetes Research and Clinical Practice|May 12, 2005
Long-term risk reduction: who needs treatment?D John Betteridge
Nature Reviews. Endocrinology|January 9, 2013
Cardiovascular endocrinology in 2012: PCSK9-an exciting target for reducing LDL-cholesterol levelsD John Betteridge
Diabetes, Obesity & Metabolism|August 19, 2007
Effects of pioglitazone on lipid and lipoprotein metabolismD John Betteridge
Current Atherosclerosis Reports|May 1, 2019
Diabetogenic Action of Statins: MechanismsRafael Carmena, D John Betteridge
Diabetes Research and Clinical Practice|July 26, 2003
CHD and diabetes--target dyslipidaemia, reduce the riskD John Betteridge, Jaakko Tuomilehto
Seminars in Vascular Medicine|April 30, 2005
Statins and diabetesRafael Carmena, D John Betteridge
Pageof 6